Gluten Guardians: FDA Extends Comment Period on Food Labels
Published Date: 3/18/2026
Notice
Summary
The FDA is giving everyone more time to share their thoughts on how gluten should be labeled and how to stop gluten from accidentally mixing into packaged foods. This affects food makers, people with celiac disease, and anyone who cares about gluten safety. Comments are now due by April 22, 2026, so get your ideas in before then!
Analyzed Economic Effects
2 provisions identified: 1 benefits, 1 costs, 0 mixed.
Potential Business Labeling and Controls Requirement
The FDA is requesting information about a petition that asks the agency to require that gluten-containing ingredients be listed by name and that manufacturers implement cross-contact controls with gluten-containing grains. The FDA extended the comment period to April 22, 2026 to allow food makers more time to respond.
FDA Seeks Input on Gluten Labeling
The FDA asked for data and information on a citizen petition (from Celiac Journey) that requests requiring that all ingredients with gluten be listed by name and that cross-contact controls with gluten-containing grains be required. The original notice published January 22, 2026 requested comments by March 23, 2026 and the FDA extended the comment deadline to April 22, 2026.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-09767 — Oscar Bobo: Final Debarment Order
Oscar Bobo is officially banned for 5 years from importing any drugs into the U.S. because he repeatedly brought in mislabeled medicines that don’t follow FDA rules. He ignored the chance to defend himself, so the ban started on May 15, 2026. This means no drug imports from him for a while, but he can apply to end the ban anytime if he meets FDA’s conditions.
2026-09448 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; The Real Cost Campaign Outcomes Evaluation Study: Cohort 3
The FDA is asking for approval to collect info for the third group in its Real Cost Campaign, which teaches kids about the dangers of tobacco. This helps the FDA improve its anti-smoking messages and protect young people’s health. Comments on this info collection are open until June 12, 2026, with no new costs for participants.
2026-09543 — Agency Information Collection Activities; Proposed Collection; Comment Request; Postmarketing Adverse Experience Reporting
The FDA wants your thoughts on how drug companies report problems after their products hit the market. This affects drug makers and healthcare folks who keep track of side effects. They’re asking for comments by July 13, 2026, to help improve the process without adding extra costs or paperwork.
2026-09544 — Modified Risk Tobacco Product Application: Renewal Applications for VLN® King and VLN® Menthol King, Cigarette Products Submitted by 22nd Century Group Inc.
The FDA is inviting the public to comment on the renewal of special approval for two cigarette products by 22nd Century Group Inc. These products claim to lower health risks compared to regular cigarettes. If approved, the renewal keeps these products on the market with their modified risk status, affecting smokers and the tobacco industry starting May 13, 2026.
2026-09335 — Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Detect and Identify Microorganism Nucleic Acids and Resistance Markers From Patients With Suspected Orthopedic Infection
Hey there! This update is all about a new medical device that helps doctors quickly find germs and their resistance traits in people who might have bone infections. It affects hospitals and labs by officially classifying this device, making it easier and faster to diagnose tough infections. The change kicks in soon, helping patients get the right treatment without delay—and it could save money by avoiding wrong meds!
2026-09368 — Enforcement Priorities for Certain New Tobacco Products Marketed Without Premarket Authorization; Guidance for Industry; Availability
The FDA is setting clear rules for certain new tobacco products like e-cigarettes and nicotine pouches that don’t have official approval yet. Companies selling these products without permission might face enforcement actions starting now, so they need to get authorized or risk penalties. This helps protect public health and keeps the market fair and safe.
Previous / Next Documents
Previous: 2026-05258 — Agency Information Collection Activities; Earth Mapping Resources Initiative (Earth MRI) Competitive Cooperative Agreement Program With State Geological Surveys
The U.S. Geological Survey is renewing its info collection for the Earth Mapping Resources Initiative (Earth MRI) program, which helps state geological surveys map and study Earth’s resources. This means states involved will keep sharing important data, helping the government plan better and reduce paperwork hassle. You’ve got until May 18, 2026, to share your thoughts, so don’t miss out!
Next: 2026-05260 — Proposed Submission of Information Collection for OMB Review; Comment Request; Direct Express Enrollment Form
The Pension Benefit Guaranty Corporation (PBGC) wants to start collecting info to help people sign up for the Direct Express debit card. This new form will make enrollment easier and more organized. If you’re affected, you can share your thoughts by May 18, 2026—no cost or hassle expected!